Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

93.90
-2.8500-2.95%
Post-market: 93.900.00000.00%19:30 EDT
Volume:948.71K
Turnover:89.37M
Market Cap:6.10B
PE:-6.67
High:97.57
Open:97.57
Low:93.57
Close:96.75
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:1.77
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-585.03
PE(LYR):-199.79

Loading ...

Mirum Pharmaceuticals price target lowered to $137 from $146 at Citizens

TIPRANKS
·
Aug 06

Mirum Pharmaceuticals, Inc. : JP Morgan Cuts Target Price to $118 from $125

THOMSON REUTERS
·
Aug 06

Stock Track | Mirum Pharmaceuticals (MIRM) Plunges 18% in 24 Hours as Q2 Loss Widens Significantly, Misses Estimates

Stock Track
·
Aug 06

Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q2 Loss -$1.06 per Share

MT Newswires Live
·
Aug 06

Mirum Pharmaceuticals, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Stock Track | Mirum Pharmaceuticals Plunges 14.18% After-Hours as Q2 Loss Widens, Misses Estimates

Stock Track
·
Aug 06

Mirum SVP, Global Controller Jolanda Howe Sells 1,840 Shares for $193,733.6

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Sales Rise, Lifts Outlook

Reuters
·
Aug 06

Mirum Q2 FY26 Operating Loss Widens to $42.54 Million; Net Sales Rise 37.91% to $176.24 Million

Reuters
·
Aug 06

Mirum Pharmaceuticals Q2 Adj. EPS $(1.06) Misses $(0.68) Estimate, Sales $176.200M Beat $166.122M Estimate

Benzinga Earnings
·
Aug 06

Mirum Pharmaceuticals Q2 Operating Income USD -42.537 Million

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 06

Mirum Pharmaceuticals Inc Expected to Post a Loss of 68 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Mirum Pharmaceuticals Updates Financial Calendar with Quarterly Results Call

Reuters
·
Jul 30

Mirum treatment of primary sclerosing cholangitis granted FDA orphan status

TIPRANKS
·
Jul 22

Arcutis Appoints Mirum CEO Chris Peetz to Board

Reuters
·
Jul 16

Mirum Grants Inducement Equity Awards to 6 New Hires, Including 6,300 Stock Options Priced at $122.13

Reuters
·
Jul 14

Mirum Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 14

Mirum CFO Eric Bjerkholt Disposes of Common Shares Worth $609,156.6

Reuters
·
Jul 09

FDA Priority Review For Zilurgisertib Could Be A Game Changer For Mirum Pharmaceuticals (MIRM)

Simply Wall St.
·
Jul 06